SCHEMBL9043043

SCHEMBL9043043

CC(C)(C)OC(=O)N[C@H](C(=O)OCc1ccccc1)c1ccc(OCCOC2CCCCCCC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CACNA1B Q00975 5/20 0.51
▸ CTSL P07711 1/20 0.45
▸ CTSS P25774 1/20 0.43
▸ CTSK P43235 1/20 0.43
▸ KLK7 P49862 2/20 0.43
▸ KLK5 Q9Y337 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ SYK P43405 1/20 0.41
▸ HRH2 P25021 1/20 0.41
▸ HRH1 P35367 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9042525 1.00 CACNA1B (0.51) CACNA1BCTSLCTSSCTSKKLK7
SCHEMBL193279 0.84 CACNA1B (0.52) CACNA1BCTSSCTSK
SCHEMBL193280 0.84 CACNA1B (0.52) CACNA1BCTSSCTSK
SCHEMBL192405 0.83 CTSS (0.54) CTSLCTSSCTSKSYK
SCHEMBL192406 0.83 CTSS (0.54) CTSLCTSSCTSKSYK
SCHEMBL23837230 0.80 CTSS (0.60) CTSLCTSSCTSKKLK7KLK5
SCHEMBL17724519 0.80 CTSS (0.60) CTSLCTSSCTSKKLK7KLK5
SCHEMBL9041727 0.80 KDM4E (0.46) KDM4EKMT2ASMN1; SMN2ALDH1A1
SCHEMBL9042933 0.80 KDM4E (0.46) KDM4EKMT2ASMN1; SMN2ALDH1A1
SCHEMBL4689229 0.79 CTSS (0.53) CTSLCTSSCTSKKLK7KLK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0512352-B1 Substituted carboxylic acid derivatives HOFFMANN LA ROCHE (CH) 1996-03-27 — — EP disclosed
US-5344843-A Carnitine acryltransferase enzyme inhibitors as antiischemic agents and for cardiovascular disorders HOFFMAN-LA ROCHE INC. (US) 1994-09-06 — — US disclosed
EP-0512352-A2 Substituted carboxylic acid derivatives F. HOFFMANN-LA ROCHE AG (CH) 1992-11-11 — — EP disclosed
Send feedback